A synthetic drug considered 100 times more potent than fentanyl was determined to have caused the death of a Riverside man, marking the latest in an increase in overdoses involving the synthetic drug, public health officials said. Carfentanil is a schedule II synthetic drug with a similar chemical as fentanyl and is used in Wildnil, an anesthetic for elephants, according …
Read More »Tag Archives: Drug
Man’s Deadly Brain Tumor Vanishes After Taking Breakthrough Drug: ‘Lucky Break in a Devastating Situation’ – AOL.com
Man’s Deadly Brain Tumor Vanishes After Taking Breakthrough Drug: ‘Lucky Break in a Devastating Situation’ AOL.comView Full Coverage on Google News Source link
Read More »This Experimental Weight Loss Drug Works Without the Nausea or Vomiting
What if you could lose weight with a drug that won’t make you lose your lunch at the same time? New research shows it might be possible. Scientists at the University of Pennsylvania, the University of Kentucky, and other institutions say they’ve found a potentially novel way to suppress people’s appetite and treat obesity—without causing the nausea or vomiting commonly …
Read More »Man's deadly brain cancer tumor disappears after experimental drug trial – AOL.com
Man’s deadly brain cancer tumor disappears after experimental drug trial AOL.comView Full Coverage on Google News Source link
Read More »Replimune's shares crater as FDA rejects melanoma drug – Fierce Biotech
Replimune’s shares crater as FDA rejects melanoma drug Fierce Biotech Replimune skin cancer therapy rejected by FDA, a sign of regulators’ hardened stance statnews.com Replimune drug rejected by FDA; Omega raises $647M biotech fund Yahoo Finance Replimmune Plummets Following FDA’s Surprise Rejection of Melanoma Treatment BioSpace Replimune Stock Plummets 75% After FDA Rejects Application for Skin Cancer Treatment Barron’s Source link
Read More »Why a long Covid drug trial failed — and what’s next
This article is published in collaboration with The Sick Times, an online publication covering long Covid. The clinical trial changed Shayna Bhalla’s life. After years with long Covid — debilitated by fatigue, headaches, and neurological issues — her symptoms dramatically receded. While not fully back to her pre-Covid-19 baseline, she was able to resume university classes and other daily activities. …
Read More »Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications | BMC Medicine
A total of 11 studies were included in this meta-analysis, including 6 studies on GLP-1 RA, 1 study on GLP-1 and GIP dual receptor agonists, 1 study on orlistat, 2 studies on phentermine-topiramate, and 1 study on naltrexone-bupropion (Additional file 1: Table S2) [22,23,24,25,26,27,28,29,30,31,32]. There were 8 placebo controls and 3 active drug controls studies with 1573 participants in the …
Read More »Missing A Tooth? Scientists Develop New Drug that Regrows Teeth
If you’re one of the millions of people who have a gaping space in your gums where a tooth used to be, there’s reason to hope you might not have to spend the rest of your days with an uneven smile or fake teeth. Scientists in Japan have announced that they are moving forward with a drug that is capable …
Read More »This Common Blood Pressure Drug Extends Lifespan, Slows Aging in Animals : ScienceAlert
The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years. Previous research has shown rilmenidine mimics the effects of caloric restriction on a cellular level. Reducing available energy while maintaining nutrition within the body has been shown to …
Read More »FDA taps biotech veteran George Tidmarsh to lead drug center
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in oncology and pediatrics, as its top drug regulator. Tidmarsh, who will be the director for the FDA’s Center for Drug Evaluation and …
Read More »